Indonesia In Vitro Diagnostics (IVD) Market Overview: 2024-2030
Base Year: 2023
Historical Years: 2019-22
Forecast Years: 2024-30
TheIndonesia In Vitro Diagnostics (IVD) Market is estimated to grow at a CAGR of about 9.35% during the forecast period, i.e., 2024-30. The factors attributing to the surge in IVD are the rising incidence of chronic ailments, growing healthcare expenditure, the increasing elderly population, and budding awareness programs for early disease detection. In recent years, the lifestyle of the individuals residing in Indonesia has drastically changed and they have been increasingly consuming unhealthy food. Also, based on the statistics by the Ministry of Health, more than 95% of individuals consume unhealthy food, including packaged & junk food.
Markntel Advisor’s Indonesia In Vitro Diagnostics (IVD) Market Insights report provides the current and forecast market analysis, individual leading companies’ market shares, challenges, Indonesia In Vitro Diagnostics (IVD) Market drivers, barriers, Indonesia In Vitro Diagnostics (IVD) Market Trends, and Key Players in Indonesia In Vitro Diagnostics (IVD) Market.
Download a sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/indonesia-ivd-market.html
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Indonesia In Vitro Diagnostics (IVD) Market Dynamics: 2024-2030
Indonesia In Vitro Diagnostics (IVD) Market Driver:
Increasing Healthcare Expenditure – In recent years, healthcare expenditure in Indonesia has increased drastically, owing to which there has been development of adequate healthcare infrastructure and greater adoption of advanced diagnostics products. During 2019-2023, Indonesia recorded economic growth and a surging middle class population. With higher disposable incomes, more inhabitants are willing to spend on healthcare services, including private healthcare. Based on the data published by the World Bank, as of 2023, almost 2% of the Indonesian population spends at least 10% of their total income on their health.
Along with this, the Indonesian health authorities are substantially investing in the healthcare sector to improve access and quality of care. The governing bodies are launching initiatives and providing subsidies & grants to expand healthcare infrastructure & enhance healthcare services. These substantial fund allocations are encouraging the hospitals to adopt next-generation diagnostics tools, including In Vitro, and provide high-quality treatment to the inhabitants, driving the Indonesia In Vitro Diagnostics Market.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/indonesia-ivd-market.html
Indonesia In Vitro Diagnostics (IVD) Market (2024-30): Segmentation Outlook
The market report has segmented the market into the following categories:
- By Product & Services
- Reagents & Kits- Market Size & Forecast 2019-2030, USD Million
- Instruments- Market Size & Forecast 2019-2030, USD Million
- Data Management Software & Techniques- Market Size & Forecast 2019-2030, USD Million
- By Technology
- Immunoassay- Market Size & Forecast 2019-2030, USD Million
- Hematology- Market Size & Forecast 2019-2030, USD Million
- Clinical Chemistry- Market Size & Forecast 2019-2030, USD Million
- Molecular Diagnostics- Market Size & Forecast 2019-2030, USD Million
- Coagulation & Hemostasis- Market Size & Forecast 2019-2030, USD Million
- Microbiology- Market Size & Forecast 2019-2030, USD Million
- Urinalysis- Market Size & Forecast 2019-2030, USD Million
- Others (Chromatography, Tissue Diagnostics, etc.)- Market Size & Forecast 2019-2030, USD Million
- By Application
- Infectious Diseases- Market Size & Forecast 2019-2030, USD Million
- Oncology – Market Size & Forecast 2019-2030, USD Million
- Cardiology- Market Size & Forecast 2019-2030, USD Million
- Nephrology- Market Size & Forecast 2019-2030, USD Million
- Diabetes- Market Size & Forecast 2019-2030, USD Million
- Drug Monitoring & Testing- Market Size & Forecast 2019-2030, USD Million
- Others (Genetic Testing, Autoimmune Diseases, etc.)- Market Size & Forecast 2019-2030, USD Million
According to report, The Oncology segment of the Indonesia In Vitro Diagnostics (IVD) Market is anticipated to grow with a significant market share over the forecast period.
- By End User
- Hospital & Clinics- Market Size & Forecast 2019-2030, USD Million
- Diagnostic Laboratories – Market Size & Forecast 2019-2030, USD Million
- Homecare Settings- Market Size & Forecast 2019-2030, USD Million
- Others (Blood Banks, Academic Institutions, etc.)- Market Size & Forecast 2019-2030, USD Million
According to report, The Hospitals & Clinics held a noteworthy share in the Indonesia IVD Market.
By Region
- Java
- Sumatra
- Kalimantan (Borneo)
- Bali
- Rest of Indonesia
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Indonesia In Vitro Diagnostics (IVD) Market:
- bioMérieux SA
- Abbott Laboratories
- PT Prodia Diagnostic Line
- Fapon Biotech Inc.
- VIRTUE Diagnostics (Suzhou) Co. Ltd.
- Siemens Healthineers Indonesia
- Qiagen
- F. Hoffmann-La Roche AG
- Sysmex Corporation
- SD Biosensor
Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
